Metabolic biomarkers of response of mantle cell lymphoma to bruton tyrosine kinase inhibition

Ended Project Grant Awarded Last action

Award ID
R01CA228457
Recipient
Awarding agency
Obligated
$5,945,235

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Funding
  • $5,443,323.00 Federal
  • $501,912.00 Non-federal
Place of performance
Pennsylvania, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $25,112 $0
Amendment $452,054 $0
Amendment $452,054 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $492,237 $0
Amendment $492,237 $0
Amendment $492,237 $0
Amendment $492,237 $0
Amendment $40,188 $0
Amendment $40,188 $0
Amendment $40,188 $0
Amendment $452,049 $0
Amendment $452,049 $0
Amendment $501,912 $0
Amendment $501,912 $501,912
Original award $516,669 $0
Show all 19

Subawards

Subrecipient Amount Awarded
Fox Chase Cancer Center Mariusz A. Wasik, M.D. (Principal Investigator on this grant application). Dr. Wasik, a Professor in the Department of Pathology at Fox Chase Cancer Center… $7,070
Fox Chase Chemical Diversity Center Inc. $127,270

Quick answers

Who received award R01CA228457?

R01CA228457 was awarded to The Trustees Of The University Of Pennsylvania by National Cancer Institute (National Institutes of Health) on March 9, 2020.

How much is award R01CA228457 worth?

$5,945,235 has been obligated on R01CA228457: $5,443,323 in federal funding and $501,912 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award